I encourage you to read the new issue of the journal “Progress in Medicine” which is totally devoted to lymphoproliferative disorders (LPD). The current issue includes valuable original papers as well as instructive case descriptions. I wish to draw your special attention for an interesting review showing current view on pathogenesis, diagnostics and treatment of patients with Hodgkin lymphoma; this paper was presented by prof. Piotr Smolewski from the Department of Experimental Haematology in Lodz.

The role of allogeneic stem cell transplantation (alloHSCT) in patients with recurrent and resistant Hodgkin lymphoma is to be established. The encouraging results of alloHSCT were presented in this journal issue.

Administration of chemotherapy may be associated with burdensome side effects. Purine analogues (PA) are frequently administered for patients with LPD and their use may be associated with significant myelo- and immunosuppression. A brief communication discussing their influence on cardiac function was presented by authors from Department of Haematology and Bone Marrow Transplantation in Katowice.